Hikal Ltd.

₹242.4

- 10.55 (-4.17%)

04:01 pm - close price

BSE: HIKAL

NSE: HIKAL

Industry: Pharmaceuticals & Drugs

House: Kalyani

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 7.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 7.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 9.88Good: 20

❌

Current Ratio

Bad: 1Current: 1.20Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.41Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 27.16Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 7.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 7.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 9.88Good: 20

❌

Current Ratio

Bad: 1Current: 1.20Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.41Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 27.16Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	388.00	434.88	447.57	514.10	406.80
Expenditure+	337.70	377.36	382.81	419.64	348.80
Other Income+	0.90	0.99	0.06	0.46	0.50
Operating Profit	50.30	57.52	64.76	94.46	58.00
Interest	13.80	13.08	14.24	15.26	19.80
Depreciation and Amortization	27.70	28.57	28.97	32.34	31.80
Profit Before Tax	9.70	16.86	21.61	47.32	6.90
Tax+	2.80	4.29	5.47	13.35	1.80
Net Profit	6.90	12.57	16.14	33.97	5.10

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	17204.36	19427.21	20230.30	17846.00	18598.00
Operational Expenses+	13975.50	16021.65	17659.61	15176.00	15314.00
Operating Profit	3228.86	3405.56	2570.69	2670.00	3284.00
Other Income	49.82	48.90	54.10	25.00	50.00
OPM %	18.77	17.53	12.71	14.96	17.66
Depreciation and Amortisation	852.45	956.69	1090.13	1176.00	1344.00
Interest	361.98	312.18	481.01	564.00	752.00
Profit Before Tax	2064.25	2185.59	1053.65	955.00	1238.00
Tax	732.85	580.60	269.83	259.00	330.00
Net Profit	1331.40	1604.99	783.82	696.00	908.00

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	20156.98	23280.29	23854.82	27635.00	28062.00
Liabilities+	20156.98	23280.29	23854.82	27635.00	28062.00

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	2290.18	2937.33	3153.09	1867.00	2804.00
Cash from Investing Activity	-1561.96	-2843.71	-2923.40	-1737.00	-1365.00
Cash from Financing Activity	-968.68	-55.58	-76.80	-270.00	-1436.00
Net Cash Flow	-240.46	38.04	152.89	-140.00	3.00
Opening Cash & Cash Equivalents	316.83	76.37	114.41	267.00	127.00
Closing Cash & Cash Equivalents	76.37	114.41	267.30	127.00	130.00

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85
Public+	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	73404	71391	68907	71801	71912	70978	71840	74657	76126	75110

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	2290.18	2937.33	3153.09	1867.00	2804.00
Cash from Investing Activity	-1561.96	-2843.71	-2923.40	-1737.00	-1365.00
Cash from Financing Activity	-968.68	-55.58	-76.80	-270.00	-1436.00
Net Cash Flow	-240.46	38.04	152.89	-140.00	3.00
Opening Cash & Cash Equivalents	316.83	76.37	114.41	267.00	127.00
Closing Cash & Cash Equivalents	76.37	114.41	267.30	127.00	130.00

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	17204.36	19427.21	20230.30	17846.00	18598.00
Operational Expenses+	13975.50	16021.65	17659.61	15176.00	15314.00
Operating Profit	3228.86	3405.56	2570.69	2670.00	3284.00
Other Income	49.82	48.90	54.10	25.00	50.00
OPM %	18.77	17.53	12.71	14.96	17.66
Depreciation and Amortisation	852.45	956.69	1090.13	1176.00	1344.00
Interest	361.98	312.18	481.01	564.00	752.00
Profit Before Tax	2064.25	2185.59	1053.65	955.00	1238.00
Tax	732.85	580.60	269.83	259.00	330.00
Net Profit	1331.40	1604.99	783.82	696.00	908.00

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	388.00	434.88	447.57	514.10	406.80
Expenditure+	337.70	377.36	382.81	419.64	348.80
Other Income+	0.90	0.99	0.06	0.46	0.50
Operating Profit	50.30	57.52	64.76	94.46	58.00
Interest	13.80	13.08	14.24	15.26	19.80
Depreciation and Amortization	27.70	28.57	28.97	32.34	31.80
Profit Before Tax	9.70	16.86	21.61	47.32	6.90
Tax+	2.80	4.29	5.47	13.35	1.80
Net Profit	6.90	12.57	16.14	33.97	5.10

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	20156.98	23280.29	23854.82	27635.00	28062.00
Liabilities+	20156.98	23280.29	23854.82	27635.00	28062.00

Ratios

Reported EPS

Bad: 2Current: 7.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 7.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 9.88Good: 20

❌

Current Ratio

Bad: 1Current: 1.20Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.41Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 27.16Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 7.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 7.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 9.88Good: 20

❌

Current Ratio

Bad: 1Current: 1.20Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 7.41Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 27.16Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85	68.85
Public+	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15	31.15
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	73404	71391	68907	71801	71912	70978	71840	74657	76126	75110

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Hikal Ltd.

₹242.4

- 10.55 (-4.17%)

04:01 pm - close price

BSE: HIKAL

NSE: HIKAL

Industry: Pharmaceuticals & Drugs

House: Kalyani

Overview